Source: Motic
PreciseDX: World-Renowned Breast Cancer Oncology and Pathology Experts to Advise Company on the Advancement of its AI-Powered PreciseBreastTM Risk of Recurrence Assessment and Product Portfolio NEW YORK, Nov. 20, 2024 /PRNewswire/...